Hims, Super Bowl and weight loss
Super Bowl ad for Hims & Hers' weight loss drug sparks backlash
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, which both contain the active ingredient semaglutide and are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes and obesity, respectively.
Hims can help with weight loss by providing the custom treatment plans, prescription medication, and over-the-counter products you need to achieve significant weight loss results. Some of ...
Hims vs. Big Pharma: Is This Telehealth Disruptor the Future of Weight Loss or a Dangerous Shortcut?
Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care products ... or a compounded weight loss formula featuring multiple ...
Hims can help with weight loss by providing the custom treatment plans, prescription medication, and over-the-counter products you need to achieve significant weight loss results. Some of ...
Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...
Ahead of the Super Bowl, telehealth company Hims & Hers on Jan. 28 released a provocative commercial attacking the weight loss industry ... about this company’s products.” ...
Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers ... misleading marketing in health products." The group also ...
Hims & Hers closes the ad by saying it is committed to being part of the solution to the weight loss drug shortage and encourages viewers to explore its products, which are considerably less ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback